We are live on
!
Find out more
AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
25 hedge funds and large institutions have $5.47M invested in Agile Therapeutics in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% more capital invested
Capital invested by funds: $5.32M → $5.47M (+$148K)
14% less funds holding
Funds holding: 29 → 25 (-4)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
25
Holders Change
-4
Holders Change %
-13.79%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
4
Reduced
7
Closed
6
Calls
$87K
Puts
–
Net Calls
+$87K
Net Calls Change
+$86K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$549K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$175K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$33.7K |
| 4 |
BlackRock
New York
|
+$13.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.19K |
